Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Brain Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 14Carcinoma, Hepatocellular 11Lung Neoplasms 10Prostatic Neoplasms 9Breast Neoplasms 5Neoplasms 4Melanoma 3Carcinoma, Renal Cell 3Small Cell Lung Carcinoma 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Stage II Prostate Adenocarcinoma AJCC v7 1Sarcoma, Ewing 1Radiation Therapy 1Radiation Injuries 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer Metastatic 1Pituitary Neoplasms 1Patients Receiving Fractionated Stereotactic Radiotherapy 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Oligometastatic Hormone Sensitive Prostate Cancer 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Nasopharyngeal Carcinoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1

Interventions

pembrolizumab 1aumolertinib 1anlotinib 1abivertinib 1Radiosurgery 1Pemetrexed 1Gefitinib 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Advanced Non-small Cell Lung Cancer × Radiosurgery × Clear all
NCT03727867 2019-01-30

Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer

Taizhou Hospital

Phase 3 Unknown
300 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡